In Situ Biologics announced it raised $3 Million in an initial filing from an offering of $3 Million
In Situ Biologics announced it raised $3 Million in an initial filing from an offering of $3 Million
12/29/23, 4:11 PM
Location
oakdaleMoney raised
$3 million
Industry
pharmaceutical manufacturing
Round Type
seed
Company Info
Location
3510 hopkins place
oakdale, pennsylvania, united states
Additional Info
InSitu Biologics is an emerging biotech company focused on development of a multi-phase prolonged release drug delivery platform for localized treatment of pain, cancer, and infection. We use disruptive technology to address unmet needs in the pain management and drug delivery markets.